2 results match your criteria: "Beijing Thoracic Tumor Hospital[Affiliation]"
[Clinical study of combined chemotherapy of domestic paclitaxel and vinorelbine plus platinum for advanced non-small cell lung cancer].
Zhongguo Fei Ai Za Zhi
June 2004
Department of Oncology, Beijing Thoracic Tumor Hospital, Beijing 101149, P.R.China.
Background: To evaluate the efficacy and toxicity of combined chemotherapy of domestic paclitaxel and vinorelbine plus cisplatin and carboplatin in the treatment of advanced non-small cell lung cancer (NSCLC).
Methods: A total of 181 initially treated patients with advanced NSCLC were enrolled in this study and treated by NP (vinorelbine plus cisplatin), TC (domestic paclitaxel plus carboplatin) and TP (domestic paclitaxel plus cisplatin). The efficacy and side effects were analysed after at least two cycles of chemotherapy.
[Second-line Hycamtin in the treatment of lung cancer].
Zhonghua Zhong Liu Za Zhi
March 2003
Department of Thoracic Surgery, Beijing Thoracic Tumor Hospital, Beijing 101149, China.
Objective: To discuss the therapeutic effect and toxicity of second line Hycamtin for lung cancer patients.
Methods: Ten of these 21 patients had been treated with operation. All these 21 patients received second line Hycamtin treatment; given at the dose of 1.